Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Stones

MET for distal ureteral calculi: not all stones are created equal

Nature Reviews Urology volume 15, pages 210–211 (2018)Cite this article

Subjects

Results of two large randomized controlled trials have challenged the use of medical expulsive therapy for the management of ureteral calculi. A new trial now shows that tamsulosin is effective in patients with distal calculi >5 mm in size, demonstrating that the effectiveness of MET depends on stone size and location.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Devenport, K., Timoney, A. G. & Keeley, F. X. Jr. Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study. Urol. Res. 35, 207–213 (2007).

    Article  Google Scholar 

  2. Campschroer, T. et al. Alpha-blockers as medical expulsive therapy for ureteral stones. Cochrane Database Syst. Rev. 4, CD008509 (2014).

    Google Scholar 

  3. Hollingsworth, J. M. et al. Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis. BMJ 355, i612–i623 (2016).

    Google Scholar 

  4. Assimos, D. et al. Surgical management of stones: American Urological Association/Endourological Society Guideline, part II. J. Urol. 196, 1161–1169 (2016).

    Article  Google Scholar 

  5. Turk, C. et al. Medical expulsive therapy for ureterolithiasis: the EAU recommendations in 2016. Eur. Urol. 71, 504–507 (2017).

    Article  Google Scholar 

  6. Pickard, R. et al. Medical expulsive therapy in adults with ureteric colic: a multicenter, randomized, placebo-controlled trial. Lancet 386, 341–349 (2015).

    Article  Google Scholar 

  7. Furyk, J. S. et al. Distal ureteric stones and tamsulosin: a double-blind, placebo-controlled, randomized, multicenter trial. Ann. Emerg. Med. 67, 86–95.e2 (2016).

    Article  Google Scholar 

  8. Ye, Z. et al. Efficacy and safety of tamsulosin in medical expulsive therapy for distal ureteral stones with renal colic: a multicenter, randomized, double-blind, placebo-controlled trial. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2017.10.033 (2017).

  9. Sur, R. L. et al. Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trial. Eur. Urol. 67, 959–964 (2015).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kelly A. Healy and Ojas Shah are at the Department of Urology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Avenue, 11th Floor, New York, New York 10032, USA.,

    Kelly A. Healy & Ojas Shah

Authors
  1. Kelly A. Healy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ojas Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ojas Shah.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Healy, K., Shah, O. MET for distal ureteral calculi: not all stones are created equal. Nat Rev Urol 15, 210–211 (2018). https://doi.org/10.1038/nrurol.2017.221

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2017.221

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing